Literature DB >> 18653779

Prolactin and ErbB4/HER4 signaling interact via Janus kinase 2 to induce mammary epithelial cell gene expression differentiation.

Rebecca S Muraoka-Cook1, Melissa Sandahl, Debra Hunter, Leah Miraglia, H Shelton Earp.   

Abstract

Differentiation of mammary epithelium in vivo requires signaling through prolactin and ErbB4/HER4-dependent mechanisms. Although stimulation of either the prolactin receptor or ErbB4/HER4 results in activation of the transcription factor signal transducer and activator of transcription 5A (STAT5A) and induction of lactogenic differentiation, how these pathways intersect is unknown. We show herein that prolactin signaling in breast cells cooperates with and is substantially enhanced by the receptor tyrosine kinase ErbB4/HER4. Prolactin and the ErbB4/HER4 ligand heparin-binding epidermal growth factor each induced STAT5A tyrosine phosphorylation and nuclear translocation; each pathway required the intracellular tyrosine kinase Janus kinase 2 (JAK2). We found that full prolactin-mediated STAT5A activation and binding to the endogenous beta-casein promoter required ErbB4/HER4 but did not require ErbB1/epidermal growth factor receptor. For example, prolactin-induced STAT5A activity was markedly diminished in cells overexpressing kinase inactive HER4, in cells transfected with small interfering RNAs to specifically knock down endogenous ErbB4/HER4 expression and in cells treated with a small molecule inhibitor that targets ErbB4 kinase. Interestingly, prolactin caused ErbB4/HER4 tyrosine phosphorylation in a JAK2 kinase-dependent manner. Finally, prolactin receptor, ErbB4/HER4, and JAK2 were coimmunoprecipitated from prolactin-treated but not untreated cells. These results suggest that prolactin signaling engages the ErbB4 pathway via JAK2 and that ErbB4 provides an important component of STAT5A-dependent lactogenic differentiation; this pathway integration may help explain the similar deficit in mammary development observed in gene-targeted mice deficient in prolactin receptor, JAK2, ErbB4, or STAT5A.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18653779      PMCID: PMC2582536          DOI: 10.1210/me.2008-0055

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  57 in total

Review 1.  The reciprocal dance between cancer and development.

Authors:  Lewis A Chodosh
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

2.  Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland.

Authors:  J A Schroeder; D C Lee
Journal:  Cell Growth Differ       Date:  1998-06

3.  Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells.

Authors:  Jianwu Xie; Matthew J LeBaron; Marja T Nevalainen; Hallgeir Rui
Journal:  J Biol Chem       Date:  2002-01-30       Impact factor: 5.157

Review 4.  Prolactin: the new biology of an old hormone.

Authors:  Vincent Goffin; Nadine Binart; Philippe Touraine; Paul A Kelly
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

5.  CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling.

Authors:  Wei-Hsuan Yu; J Frederick Woessner; John D McNeish; Ivan Stamenkovic
Journal:  Genes Dev       Date:  2002-02-01       Impact factor: 11.361

Review 6.  Prolactin and mammary gland development.

Authors:  N D Horseman
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

Review 7.  Prolactin receptor signal transduction.

Authors:  C V Clevenger; J B Kline
Journal:  Lupus       Date:  2001       Impact factor: 2.911

8.  Prolactin controls mammary gland development via direct and indirect mechanisms.

Authors:  C Brisken; S Kaur; T E Chavarria; N Binart; R L Sutherland; R A Weinberg; P A Kelly; C J Ormandy
Journal:  Dev Biol       Date:  1999-06-01       Impact factor: 3.582

9.  gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase.

Authors:  C Y Ni; M P Murphy; T E Golde; G Carpenter
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

10.  Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.

Authors:  Juan J Acosta; Raúl M Muñoz; Lorena González; Alicia Subtil-Rodríguez; Maria Aurora Dominguez-Caceres; José Manuel García-Martínez; Annarica Calcabrini; Iciar Lazaro-Trueba; Jorge Martín-Pérez
Journal:  Mol Endocrinol       Date:  2003-08-07
View more
  9 in total

1.  Basal cell signaling by p63 controls luminal progenitor function and lactation via NRG1.

Authors:  Nicole Forster; Srinivas Vinod Saladi; Maaike van Bragt; Mary E Sfondouris; Frank E Jones; Zhe Li; Leif W Ellisen
Journal:  Dev Cell       Date:  2014-01-09       Impact factor: 12.270

2.  Molecular modeling of ErbB4/HER4 kinase in the context of the HER4 signaling network helps rationalize the effects of clinically identified HER4 somatic mutations on the cell phenotype.

Authors:  Shannon E Telesco; Rajanikanth Vadigepalli; Ravi Radhakrishnan
Journal:  Biotechnol J       Date:  2013-12-04       Impact factor: 4.677

3.  Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.

Authors:  Elena Pedraz-Cuesta; Jacob Fredsted; Helene H Jensen; Annika Bornebusch; Lene N Nejsum; Birthe B Kragelund; Stine F Pedersen
Journal:  Mol Endocrinol       Date:  2016-05-13

Review 4.  Tumor necrosis factor-alpha-converting enzyme activities and tumor-associated macrophages in breast cancer.

Authors:  Stephen L Rego; Rachel S Helms; Didier Dréau
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

5.  Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling.

Authors:  Jasna Bancovik; Dayson F Moreira; Daniel Carrasco; Jun Yao; Dale Porter; Ricardo Moura; Anamaria Camargo; Cibely C Fontes-Oliveira; Miguel G Malpartida; Silvia Carambula; Edouard Vannier; Bryan E Strauss; Alda Wakamatsu; Venancio Af Alves; Angela F Logullo; Fernando A Soares; Kornelia Polyak; José E Belizário
Journal:  BMC Cancer       Date:  2015-02-19       Impact factor: 4.430

Review 6.  Regulation of the JAK2-STAT5 Pathway by Signaling Molecules in the Mammary Gland.

Authors:  Min Tian; Yingao Qi; Xiaoli Zhang; Zhihui Wu; Jiaming Chen; Fang Chen; Wutai Guan; Shihai Zhang
Journal:  Front Cell Dev Biol       Date:  2020-11-17

Review 7.  The Mammary Gland: Basic Structure and Molecular Signaling during Development.

Authors:  Swarajit Kumar Biswas; Saswati Banerjee; Ginger Wendolyn Baker; Chieh-Yin Kuo; Indrajit Chowdhury
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 6.208

8.  Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells.

Authors:  Vikram B Wali; Jonathan W Haskins; Maureen Gilmore-Hebert; James T Platt; Zongzhi Liu; David F Stern
Journal:  Mol Cancer Res       Date:  2014-05-14       Impact factor: 6.333

9.  ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation.

Authors:  Michelle M Williams; David B Vaught; Meghan Morrison Joly; Donna J Hicks; Violeta Sanchez; Philip Owens; Bushra Rahman; David L Elion; Justin M Balko; Rebecca S Cook
Journal:  Breast Cancer Res       Date:  2017-09-08       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.